YHYuki Himoto

Yuki Himoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuki Himoto has a total of 205 co-authors. Here are the top co-authors by number of shared publications:

  • Aki Kido

    Department of Radiology, Faculty of Medicine University of Toyama Toyama Japan

    23 shared publications
  • Aki Kido

    Department of Radiology Toyama University Hospital Toyama Japan

    11 shared publications
  • Koji Fujimoto

    Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan

    11 shared publications
  • Yasuhisa Kurata

    Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan

    11 shared publications
  • Kaori Togashi

    Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    10 shared publications
  • Sachiko Minamiguchi

    Department of Diagnostic Pathology Fujita Health University Nagoya Japan

    10 shared publications

Latest Publications

  • Clinical significance of MRI-based tumor status differs by histological subtype in early-stage cervical cancer

    by Kazuhiro Kou, Koji Yamanoi, Hisanori Kobara, Hiroaki Komatsu, Yuki Himoto, Hiroaki Ito, Mana Maehara, Ayumi Ohya, Shinya Fujii, Yoshihide Inayama, et al.

  • Progressive MRI changes in lobular endocervical glandular hyperplasia suggesting malignant transformation: report of two cases with histopathologic correlation

    by Takahito Niiyama, Aki Kido, Hideto Kawabe, Yuki Himoto, Ken Yamaguchi, Hideo Yoshimoto, Sachiko Minamiguchi, Naotaka Yamauchi, Kazuhiro Matsui, Masaki Mandai, et al.

    Lobular endocervical glandular hyperplasia (LEGH), a benign multicystic lesion that typically occurs in the upper uterine cervix, is regarded as a potential precursor lesion of gastric-type adenocarcinoma (GAS), including its well-differentiated form, minimal deviation adenocarcinoma (MDA). On MRI, LEGH characteristically shows the “cosmos sign,” consisting of clustered small central cysts surrounded by larger peripheral cysts on T2-weighted images. However, MDA arising from LEGH can yield similar findings. Differentiation by MRI is therefore often challenging. This report describes two premenopausal women with MDA associated with previously diagnosed LEGH who underwent serial MRI follow-up. In both cases, T2-weighted images showing the cosmos sign revealed progressive enlargement of a central hypointense area with concomitant shrinkage of the surrounding cysts. Neither showed any readily apparent increase in overall lesion size. During follow-up after the initial diagnosis/conization, cytology remained negative for intraepithelial lesion or malignancy. In case 1, hysterectomy revealed MDA associated with previously diagnosed LEGH. The central hypointense area corresponded to tumor-associated reactive fibrotic stroma containing infiltrative glands with nuclear enlargement and mitoses. In case 2, hysterectomy showed deeply extending, morphologically diverse glands associated with reactive fibrotic stroma suspicious for invasion. The central hypointense area again corresponded to predominantly fibrotic stroma. These cases suggest that progressive expansion of a central low-signal-intensity area on T2-weighted images, accompanied by shrinkage of peripheral cysts, might constitute an early imaging sign of transition from LEGH to MDA, even without overall LEGH enlargement or worsening cytology. Such expansion should therefore be assessed carefully on follow-up MRI.

  • Risk Stratification Based on Imaging Findings for Pregnancies With Subamniotic or Subchorionic Hematoma on Placental MRI

    by Kumi Harada, Yuki Himoto, Yoshitsugu Chigusa, Seiichi Tomotaki, Yasuhisa Kurata, Atsushi Yoshida, Yuriko Muramatsu, Yu Hidaka, Satoshi Morita, Yuka Kuriyama Matsumoto, et al.

    Background: Subamniotic or subchorionic hematoma (SAH/SCH) is associated with diverse pregnancy outcomes. The clinical implications of accompanying oligohydramnios and hemorrhagic amniotic fluid on MRI remain unclear. Purpose: To investigate the importance of oligohydramnios and hemorrhagic amniotic fluid on placental MRI for SAH/SCH in risk stratification. Study Type: Retrospective. Population: Seventy‐one singleton pregnancies with SAH/SCH identified on placental MRI performed during the second or third trimesters, from 2016 to 2023. Field Strength/Sequence: 1.5 T, Fat‐saturated T1‐weighted gradient echo and half‐Fourier‐acquired single‐shot turbo spin echo sequences. Assessment: Cases were classified into three groups: Groups A (oligohydramnios and hemorrhagic amniotic fluid), B (either oligohydramnios or hemorrhagic amniotic fluid), and C (SAH or SCH only). Groups B and C were subclassified as B‐1 (oligohydramnios), B‐2 (hemorrhagic amniotic fluid), C‐1 (detected hematoma on ultrasound before MRI), and C‐2 (incidentally detected hematoma on MRI). Unfavorable obstetric outcome (abortion or birth before 34 gestational weeks) and neonatal outcome (duration of neonatal intensive care unit [NICU] stay) were compared. Statistical Tests: Fisher's exact test, Kruskal–Wallis test, Mann–Whitney U test, and Kaplan–Meier analysis with Log‐rank test. Significance was determined at p < 0.05. Results: Unfavorable obstetric outcomes were significantly higher in Group A (11/12, 91.7%) than groups B (6/17, 35.3%) and C (9/42, 21.4%). Significant differences were found among the five subclassified groups, most notably between B‐1 and B‐2. The median duration of NICU stay was 87, 30.5, 0, 25, and 8 days in Groups A ( n = 12), B‐1 ( n = 5), B‐2 ( n = 12), C‐1 ( n = 11), and C‐2 ( n = 31), respectively. Group A showed the worst neonatal outcomes. Data Conclusion: MRI findings of oligohydramnios and/or hemorrhagic amniotic fluid in pregnancies with SAH/SCH are associated with adverse obstetric and neonatal outcomes, supporting risk stratification. Evidence Level: 4. Technical Efficacy: Stage 5.

  • Open Access

    Multicenter Study of MRI Features in Uterine Myxoid Leiomyosarcoma: Revealing and Overcoming a Critical Pitfall in Current Consensus Criteria

    by Tsukasa Saida, Natsumi Kawamatsu, Shinya Fujii, Saki Shibuki, Nao Kikkawa, Go Nakai, Yuki Himoto, Hideyuki Fukui, Takahiro Ueda, Ayumi Ohya, et al.

    Saida T, et al. Korean J Radiol. 2026 Sep;27(9):878-889. https://doi.org/10.3348/kjr.2026.0457


  • Open Access

    A Case of Liver Hemorrhage Uncontrollable by Transarterial Embolization after Percutaneous Liver Biopsy in a Patient with Intravascular Large B-cell Lymphoma

    by Yuki Himoto, Yasuyuki Onishi, Yuito Michiwaki, Yuichi Tsuji, Tsuyoshi Ohno, Hironori Shimizu, Hiroshi Arima, Chisaki Mizumoto, Shigeharu Nakano, Yuki Masano, et al.

    Intravascular large B-cell lymphoma is a rare, aggressive lymphoma characterized by intravascular growth. The liver is a common site of involvement. Although liver biopsy provides sufficient tissue for diagnosis and treatment planning, it carries a risk of severe hemorrhage. This report describes the case of a woman in her 50s with intravascular large B-cell lymphoma who developed liver hemorrhage that was uncontrollable by transarterial embolization after undergoing ultrasound-guided percutaneous liver biopsy, necessitating laparoscopic hemostasis. Pathological findings revealed markedly dilated liver sinusoids filled with tumor cells, suggesting direct hemorrhage from these vessels. This case highlights the potential for increased hemorrhage risk in intravascular large B-cell lymphoma and underscores the necessity for careful consideration of alternative biopsy techniques, such as the transjugular approach or percutaneous biopsy with tract embolization.

  • Open Access

    Magnetic resonance imaging features of mesonephric-like adenocarcinoma of the uterine corpus in comparison with endometrial endometrioid carcinoma: Multi-institutional study

    by Saki Yamamoto, Mitsuru Matsuki, Sota Masuoka, Tomohiro Kikuchi, Atsushi Kihara, Naoki Sano, Noriyoshi Fukushima, Hiroyuki Fujiwara, Hiroki Kato, Yuki Himoto, et al.


  • Thoracic and Diaphragmatic Endometriosis

    by Aki Kido, Yuki Himoto, Toshihiro Ojima, Tomoshi Tsuchiya

  • A case of uterine leiomyosarcoma in a survivor of hereditary retinoblastoma

    by Mitsuhiro Kirita, Yuki Himoto, Yuka Kuriyama Matsumoto, Yasuhisa Kurata, Aki Kido, Yusuke Yamaoka, Koji Yamanoi, Masaki Mandai, Sachiko Minamiguchi, Yuji Nakamoto

    Survivors of hereditary retinoblastoma have increased risk of subsequent primary malignancies due to RB1 mutation. We report uterine leiomyosarcoma (LMS) in a hereditary retinoblastoma survivor. She had follow-up for leiomyomas, with pelvic MRI showing typical leiomyomas two years prior. She presented with abdominal distention, and MRI revealed a massive tumor with LMS characteristics where a leiomyoma was previously observed. Chest CT showed a nodule suspicious for metastasis in the left lung. Total hysterectomy with bilateral salpingo-oophorectomy and partial lung resection was performed. Pathology confirmed LMS with pulmonary metastasis. Immunostaining showed complete RB1 loss in tumor cells. LMS was suspected to have arisen near a pre-existing leiomyoma or resulted from its malignant transformation. Continuous follow-up is necessary in hereditary retinoblastoma survivors. Graphical abstract


  • Diagnostic Imaging of Postoperative Complications

    by Yuki Himoto, Fuki Shitano, Aki Kido, Shigeaki Umeoka

  • Differentiating uterine adenosarcoma from endometrial polyps: MRI imaging features

    by Kumi Harada, Yasuhisa Kurata, Yuki Himoto, Aki Kido, Mitsuhiro Kirita, Atsushi Yoshida, Yuka Kuriyama Matsumoto, Junzo Hamanishi, Sachiko Minamiguchi, Hiroaki Ito, et al.

    Objective This study was conducted to identify MRI features distinguishing uterine adenosarcoma from endometrial polyps and to predict the presence or absence of sarcomatous overgrowth (SO), a pathological finding linked to poor prognosis. Methods This multicenter retrospective study included 11 cases of uterine adenosarcoma, with 5 showing SO and 6 without, and 20 cases of endometrial polyps measuring 3 cm or greater diameter. Quantitative evaluations (tumor volume, cystic lesion size, diffusion-weighted imaging [DWI] signal ratio, apparent diffusion coefficient [ADC] value, and normalized ADC value) and qualitative evaluations (degree of hemorrhage, signal intensity on T2-weighted imaging and DWI, number of cystic lesions, degree of contrast enhancement, and tumor localization) were performed. The evaluation parameters were compared between uterine adenosarcoma and endometrial polyp groups, and between SO and non-SO subgroups within uterine adenosarcoma. Results Uterine adenosarcoma had significantly larger tumor volumes (median 192,324 mm³ vs. 15,717 mm³, p < 0.001), larger cystic lesions (median 17.7 mm vs. 6.7 mm, p = 0.0074), and higher DWI signal ratios (median 1.50 vs. 1.08, p = 0.008) along with significantly lower ADC values (median 961.5 × 10− 6 mm²/s vs. 1222.3 × 10− 6 mm²/s, p = 0.048) and normalized ADC values (median 0.34 vs. 0.49, p = 0.001) compared to endometrial polyps. Gross hemorrhage (9/11 vs. 1/20, p < 0.001) and high signal intensity on DWI (10/11 vs. 4/20, p < 0.001) were observed more frequently with uterine adenosarcomas. No significant difference was found between uterine adenosarcomas with SO and without SO for any quantitative or qualitative evaluation parameter. Conclusions This study identified key imaging features of uterine adenosarcoma, including larger tumor volume, larger cystic lesions, gross intratumoral hemorrhage, higher DWI signal intensity, and lower ADC values. These findings can facilitate preoperative differentiation of uterine adenosarcoma from endometrial polyps.